// App-Quantinova.ai

PB0169 : Proof of principle of a fast and fully automated FVIII functional inhibitor test

Researchers

Presenter

  • B. Verbruggen

Principal Investigators

  • N. Binder

  • G. Moore

Medical Centers

  • Hemostad, Nijmegen, Gelderland, Netherlands

  • Technoclone Herstellung von Diagnostika und Arzneimitteln GmbH, Vienna, Austria

  • Cambridge University Hospitals, Bexley, England, United Kingdom

  • Hemostad, Nijmegen, Gelderland, Netherlands

Locations

  • Netherlands

  • Austria

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • FVIII

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved